Cardiovascular disease mortality and serum carotenoid levels: a Japanese population-based follow-up study

Yoshinori Ito1, Mio Kurata, Koji Suzuki

  • 1Department of Preventive Medicine/Biostatistics and Medical Decision Making, Nagoya University Graduate School of Medicine, Japan. itoyo@med.nagoya-u.ac.jp

Insights

High serum carotenoids, including alpha-carotene, beta-carotene, and lycopene, are linked to lower cardiovascular disease mortality in Japanese adults. This suggests a protective role for these dietary compounds in heart health.

Area of Science:

  • Nutritional Epidemiology
  • Cardiovascular Health
  • Biomarkers

Background:

  • Observational studies suggest a link between dietary and serum carotenoids and reduced cardiovascular disease (CVD) mortality.
  • Carotenoids are antioxidants with potential cardioprotective effects.

Purpose of the Study:

  • To investigate the association between serum carotenoid levels and CVD mortality in a Japanese cohort.
  • To determine if specific carotenoids (alpha-carotene, beta-carotene, lycopene) or total carotene influence CVD risk.

Main Methods:

  • A cohort of 3,061 Japanese adults (aged 39-80) was followed for 11.9 years.
  • Serum levels of alpha-carotene, beta-carotene, and lycopene were measured using high-performance liquid chromatography.
  • Cox proportional hazard models adjusted for confounders were used to estimate hazard ratios for CVD mortality.

Main Results:

  • High serum levels of alpha-carotene, beta-carotene, and total carotene were significantly associated with lower CVD mortality.
  • A significant inverse association between high serum lycopene and stroke mortality was not consistently observed.
  • 80 CVD deaths, 40 heart disease deaths, and 37 stroke deaths occurred during follow-up.

Conclusions:

  • Elevated serum total carotene, primarily from alpha- and beta-carotenes and lycopene, may reduce cardiovascular disease mortality risk.
  • These findings support the potential cardioprotective role of carotenoids in the Japanese population.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...